A study conducted bà Cattolica in Rome and the Fondazione Policlinico Universitario Agostino Gemelli IRCCS has uncovered a ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

"It has been linked to a variety of medical conditions including cardiovascular disease, stroke, obesity, diabetes, anxiety ...

Opens in a new tab or window Esketamine nasal spray (Spravato) monotherapy was helpful in improving symptoms of treatment-resistant depression, a randomized, double-blind trial found. Among 379 ...

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication ...

Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...

FDA reported that, for now, companies can continue to market OTC monograph drug products containing oral phenylephrine as a ...

A new nasal spray form of the medication bumetanide may reduce the tissue swelling caused by heart failure as effectively as the standard oral and intravenous formulations of the medication, according ...

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe and well-tolerated (meaning with no significant nasal irritation ...

COLLEGE STATION, Texas — November is National Alzheimer's Awareness Month and now a new therapy out of Texas A&M University could treat Alzheimer's disease through a nasal spray. Seven million ...